Citadel Advisors’s Covisint Corporation COVS Stock Holding History

Citadel Advisors’s Portfolio COVS Stock Details COVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-42,290	Closed	-$104K	–	8492
2017 Q2	$104K	Buy	+42,290	New	+$88.3K	﹤0.01%	6893
2016 Q2	–	Sell	-13,507	Closed	-$27K	–	7809
2016 Q1	$27K	Buy	+13,507	New	+$27.4K	﹤0.01%	6405
2015 Q3	–	Sell	-47,379	Closed	-$155K	–	9475
2015 Q2	$155K	Buy	47,379 +7,074	+18%	+$16.8K	﹤0.01%	6628
2015 Q1	$81K	Buy	40,305 +29,026	+257%	+$67.7K	﹤0.01%	7021
2014 Q4	$30K	Buy	+11,279	New	+$32.3K	﹤0.01%	7563
2013 Q4	–	Sell	-107,786	Closed	-$1.38M	–	7306
2013 Q3	$1.38M	Buy	+107,786	New	+$1.36M	﹤0.01%	2772

Citadel Advisors's COVS Position: Q3 2017 in Review

Citadel Advisors sold out of Covisint Corporation (COVS) in Q3 2017, closing a stake of 42,290 shares — an estimated $104K sold.

Citadel Advisors first reported a position in COVS in Q3 2013 and held it in 6 quarters. The position peaked at $1.38M in Q3 2013. 0 funds tracked by Wall St. Rank hold COVS as of Q3 2017.

Citadel Advisors reported no remaining Covisint Corporation position as of Q3 2017 after selling out during the quarter.
Citadel Advisors sold 42,290 Covisint Corporation shares in Q3 2017, an estimated $104K.
Citadel Advisors first reported a position in Covisint Corporation in Q3 2013 and held it in 6 quarters.
Citadel Advisors's Covisint Corporation position peaked at $1.38M in Q3 2013.
0 funds tracked by Wall St. Rank held Covisint Corporation as of Q3 2017.

Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.